TCM gets nod to finalize potential acquisition of Edayar Zinc

12 Feb 2019 Evaluate

TCM has received an approval to negotiate, finalize the terms and conditions of the proposed potential acquisition of Edayar Zinc shares within the company and sign on behalf of the Company the final ‘Term Sheet’ for the said potential acquisition and also in all necessary documents.

The Board of the company at their meeting held on February 12, 2019, authorized Joseph Varghese, Managing Director to negotiate, finalize the same.

TCM is engaged in the manufacture of Potassium Chlorate – a vital raw material for the match Industry.

TCM Share Price

69.52 -2.78 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×